JPWO2023018870A5 - - Google Patents
Info
- Publication number
- JPWO2023018870A5 JPWO2023018870A5 JP2024507886A JP2024507886A JPWO2023018870A5 JP WO2023018870 A5 JPWO2023018870 A5 JP WO2023018870A5 JP 2024507886 A JP2024507886 A JP 2024507886A JP 2024507886 A JP2024507886 A JP 2024507886A JP WO2023018870 A5 JPWO2023018870 A5 JP WO2023018870A5
- Authority
- JP
- Japan
- Prior art keywords
- liquid composition
- antibody
- seq
- variable region
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232299P | 2021-08-12 | 2021-08-12 | |
| US63/232,299 | 2021-08-12 | ||
| US202263316604P | 2022-03-04 | 2022-03-04 | |
| US63/316,604 | 2022-03-04 | ||
| PCT/US2022/040056 WO2023018870A1 (en) | 2021-08-12 | 2022-08-11 | Antibody formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532736A JP2024532736A (ja) | 2024-09-10 |
| JPWO2023018870A5 true JPWO2023018870A5 (https=) | 2025-08-13 |
| JP2024532736A5 JP2024532736A5 (https=) | 2025-08-13 |
Family
ID=83151728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507886A Pending JP2024532736A (ja) | 2021-08-12 | 2022-08-11 | 抗体処方物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240343795A1 (https=) |
| EP (1) | EP4384217A1 (https=) |
| JP (1) | JP2024532736A (https=) |
| KR (1) | KR20240046881A (https=) |
| AU (1) | AU2022325870A1 (https=) |
| CA (1) | CA3228269A1 (https=) |
| CL (1) | CL2024000401A1 (https=) |
| CO (1) | CO2024001383A2 (https=) |
| CR (1) | CR20240130A (https=) |
| IL (1) | IL310275A (https=) |
| JO (1) | JOP20240024A1 (https=) |
| MX (1) | MX2024001934A (https=) |
| PE (1) | PE20240650A1 (https=) |
| TW (1) | TW202319398A (https=) |
| UY (1) | UY39896A (https=) |
| WO (1) | WO2023018870A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026062214A1 (en) * | 2024-09-19 | 2026-03-26 | Sanofi | Formulations comprising lunsekimig |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201605896A (zh) | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
| EP2963057A1 (en) | 2014-07-02 | 2016-01-06 | Calypso Biotech SA | Antibodies to IL-15 |
| WO2017217985A1 (en) | 2016-06-15 | 2017-12-21 | Amgen Inc. | Methods and compositions for the treatment of celiac disease, non-celiac gluten sensitivity, and refractory celiac disease |
| WO2018119142A1 (en) * | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| MA48464A (fr) * | 2017-04-28 | 2020-03-04 | Amgen Inc | Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques |
| EA201992570A1 (ru) | 2017-04-28 | 2020-03-20 | Эмджен Инк. | Составы на основе человеческих антител к rankl, а также способы их применения |
| TW201930344A (zh) | 2018-01-12 | 2019-08-01 | 美商安進公司 | 抗ｐｄ-１抗體及治療方法 |
| WO2021079337A1 (en) * | 2019-10-23 | 2021-04-29 | Cadila Healthcare Limited | Pharmaceutical formulation of anti-her2 antibody and preparation thereof |
-
2022
- 2022-08-11 AU AU2022325870A patent/AU2022325870A1/en active Pending
- 2022-08-11 MX MX2024001934A patent/MX2024001934A/es unknown
- 2022-08-11 KR KR1020247007623A patent/KR20240046881A/ko active Pending
- 2022-08-11 WO PCT/US2022/040056 patent/WO2023018870A1/en not_active Ceased
- 2022-08-11 EP EP22762210.7A patent/EP4384217A1/en active Pending
- 2022-08-11 PE PE2024000233A patent/PE20240650A1/es unknown
- 2022-08-11 CR CR20240130A patent/CR20240130A/es unknown
- 2022-08-11 CA CA3228269A patent/CA3228269A1/en active Pending
- 2022-08-11 US US18/682,531 patent/US20240343795A1/en active Pending
- 2022-08-11 JP JP2024507886A patent/JP2024532736A/ja active Pending
- 2022-08-11 IL IL310275A patent/IL310275A/en unknown
- 2022-08-11 UY UY0001039896A patent/UY39896A/es unknown
- 2022-08-11 TW TW111130262A patent/TW202319398A/zh unknown
-
2024
- 2024-02-08 CO CONC2024/0001383A patent/CO2024001383A2/es unknown
- 2024-02-08 JO JOJO/P/2024/0024A patent/JOP20240024A1/ar unknown
- 2024-02-09 CL CL2024000401A patent/CL2024000401A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512881A5 (https=) | ||
| CN102946858B (zh) | 含有免疫球蛋白Fc的多肽的液体制剂 | |
| JP2022174082A5 (https=) | ||
| JP2024099682A5 (https=) | ||
| RU2011127913A (ru) | Составы, содержащие антитела | |
| CN102753147B (zh) | 长效红细胞生成素缀合物的液体制剂 | |
| RU2015111341A (ru) | Композиции антитела и белка | |
| JP2024160287A5 (https=) | ||
| JP2021503485A5 (https=) | ||
| JP2024010026A5 (https=) | ||
| JP6010155B2 (ja) | 組み換え技術によって製造された第ｖｉｉｉ因子のための新規な保護組成物 | |
| WO2021058005A1 (zh) | 一种人源化抗人il-17a单克隆抗体的药物组合物 | |
| JP2022023223A5 (https=) | ||
| JPWO2023018870A5 (https=) | ||
| IL319239A (en) | Stable antibody preparation | |
| JPWO2022178159A5 (https=) | ||
| RU2012131162A (ru) | Композиции вакцин | |
| JPWO2022178158A5 (https=) | ||
| JPWO2022026914A5 (https=) | ||
| JP2021521168A5 (https=) | ||
| JPWO2023081652A5 (https=) | ||
| JPWO2021263134A5 (https=) | ||
| RU2016152691A (ru) | Водная фармацевтическая композиция рекомбинантного моноклонального антитела к ФНОα | |
| JPWO2021067775A5 (https=) | ||
| JPWO2022256359A5 (https=) |